According to Huitai Medical's announcement, Cheng Zhenghui, the shareholder, vice chairman and general manager of the company holds more than 5% of the company's shares, holding 236.08 million shares, accounting for 16.6756% of the company's total share capital. Cheng Zhenghui plans to reduce his holdings of the company by no more than 2.122,900 shares, or no more than 1.5% of the company's total share capital, through bulk transactions. The reduction period is from October 20, 2026 to January 19, 2027. The reason for the reduction is his own capital requirements. There is uncertainty about the implementation of this holdings reduction plan and will not lead to a change in the company's control.

According to Huitai Medical's announcement, Cheng Zhenghui, the shareholder, vice chairman and general manager of the company holds more than 5% of the company's shares, holding 236.08 million shares, accounting for 16.6756% of the company's total share capital. Cheng Zhenghui plans to reduce his holdings of the company by no more than 2.122,900 shares, or no more than 1.5% of the company's total share capital, through bulk transactions. The reduction period is from October 20, 2026 to January 19, 2027. The reason for the reduction is his own capital requirements. There is uncertainty about the implementation of this holdings reduction plan and will not lead to a change in the company's control.